PeproTech Inc.
Originally published online as doi:10.1189/jlb.0906590 on December 8, 2006

Published online before print December 8, 2006
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jlb.0906590v1
81/3/711    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Odegaard, J. I.
Right arrow Articles by Chawla, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Odegaard, J. I.
Right arrow Articles by Chawla, A.
(Journal of Leukocyte Biology. 2007;81:711-719.)
© 2007 by Society for Leukocyte Biology

Quantitative expansion of ES cell-derived myeloid progenitors capable of differentiating into macrophages

Justin I. Odegaard*, Divya Vats*, Lina Zhang*, Roberto Ricardo-Gonzalez*, Kristi L. Smith*, David B. Sykes{dagger},{ddagger}, Mark P. Kamps{dagger} and Ajay Chawla*,1

* Division of Endocrinology, Metabolism and Gerontology, Department of Medicine and Graduate Program in Immunology, Stanford University School of Medicine, Stanford, California, USA;
{dagger} Department of Pathology and Molecular Pathology Graduate Program, University of California at San Diego, La Jolla, California, USA; and
{ddagger} Deparment of Medicine, Harvard Massachusetts General Hospital, Boston, Massachusetts, USA

1 Correspondence: Division of Endocrinology, Metabolism and Gerontology, Department of Medicine and Graduate Program in Immunology, Stanford University School of Medicine, Stanford, CA 94305-5103, USA. E-mail: achawla{at}stanford.edu

Macrophages participate in physiologic and pathologic processes through elaboration of distinct activation programs. Studies with macrophage cell systems have revealed much concerning the importance of this pleiotropic cell; however, these studies are inherently limited by three factors: heterogeneity of the target cell population, poor capacity to elaborate various activation programs, and lack of a genetically tractable model system for loss- and gain-of-function studies. Although definitive, hematopoietic lineages can be isolated from embryonic stem (ES) cells, these isolation procedures are inefficient and time-consuming and require elaborate cell-sorting protocols. We therefore examined whether myeloid precursors, capable of differentiating into macrophages, could be conditionally expanded in vitro. Here, we report methods for selective isolation and immortalization of ES cell-derived myeloid precursors by estrogen-regulated HoxA9 protein. Using this new macrophage differentiation system, an unlimited number of custom-designed macrophages with defined functional characteristics can be generated from any targeted ES cell. In combination with knockout or small interfering RNA knockdown technologies, this macrophage differentiation system provides a powerful tool for high throughput analysis of regulatory mechanisms controlling macrophage activation in health and disease.

Key Words: cell line • alternative activation • classical activation




This article has been cited by other articles:


Home page
Stem CellsHome page
S. Senju, M. Haruta, Y. Matsunaga, S. Fukushima, T. Ikeda, K. Takahashi, K. Okita, S. Yamanaka, and Y. Nishimura
Characterization of Dendritic Cells and Macrophages Generated by Directed Differentiation from Mouse Induced Pluripotent Stem Cells
Stem Cells, May 1, 2009; 27(5): 1021 - 1031.
[Abstract] [Full Text] [PDF]